ATE302186T1 - Derivate von 3-phenyl-2, 6-dioxopiperidin-3-yl propionamide und verfahren zur deren herstellung - Google Patents

Derivate von 3-phenyl-2, 6-dioxopiperidin-3-yl propionamide und verfahren zur deren herstellung

Info

Publication number
ATE302186T1
ATE302186T1 AT99973409T AT99973409T ATE302186T1 AT E302186 T1 ATE302186 T1 AT E302186T1 AT 99973409 T AT99973409 T AT 99973409T AT 99973409 T AT99973409 T AT 99973409T AT E302186 T1 ATE302186 T1 AT E302186T1
Authority
AT
Austria
Prior art keywords
phenyl
propionamide
derivatives
dioxopiperidine
production
Prior art date
Application number
AT99973409T
Other languages
English (en)
Inventor
Bertrand Castro
Helene Mattras
Aldo Previero
Original Assignee
Sanofi Aventis
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanofi Aventis filed Critical Sanofi Aventis
Application granted granted Critical
Publication of ATE302186T1 publication Critical patent/ATE302186T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/16—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms
    • C07D295/18—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms by radicals derived from carboxylic acids, or sulfur or nitrogen analogues thereof
    • C07D295/182—Radicals derived from carboxylic acids
    • C07D295/185—Radicals derived from carboxylic acids from aliphatic carboxylic acids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C235/00—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms
    • C07C235/70—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups and doubly-bound oxygen atoms bound to the same carbon skeleton
    • C07C235/72—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups and doubly-bound oxygen atoms bound to the same carbon skeleton with the carbon atoms of the carboxamide groups bound to acyclic carbon atoms
    • C07C235/76—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups and doubly-bound oxygen atoms bound to the same carbon skeleton with the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of an unsaturated carbon skeleton
    • C07C235/78—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups and doubly-bound oxygen atoms bound to the same carbon skeleton with the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of an unsaturated carbon skeleton the carbon skeleton containing rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/08—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
    • C07D211/18—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D211/26—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by nitrogen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/80—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
    • C07D211/84—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen directly attached to ring carbon atoms
    • C07D211/86—Oxygen atoms
    • C07D211/88—Oxygen atoms attached in positions 2 and 6, e.g. glutarimide
AT99973409T 1998-12-15 1999-12-01 Derivate von 3-phenyl-2, 6-dioxopiperidin-3-yl propionamide und verfahren zur deren herstellung ATE302186T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR9816088A FR2787449B3 (fr) 1998-12-15 1998-12-15 Derives de 3-phenyl-2,6-dioxopiperidin-3-yl propionamide et leur procede de preparation
PCT/FR1999/002971 WO2000035879A1 (fr) 1998-12-15 1999-12-01 Derives de 3-phenyl-2, 6-dioxopiperidin-3-yl propionamide et leur procede de preparation

Publications (1)

Publication Number Publication Date
ATE302186T1 true ATE302186T1 (de) 2005-09-15

Family

ID=9534204

Family Applications (1)

Application Number Title Priority Date Filing Date
AT99973409T ATE302186T1 (de) 1998-12-15 1999-12-01 Derivate von 3-phenyl-2, 6-dioxopiperidin-3-yl propionamide und verfahren zur deren herstellung

Country Status (9)

Country Link
US (2) US6342607B1 (de)
EP (1) EP1140841B1 (de)
JP (1) JP2002532474A (de)
AT (1) ATE302186T1 (de)
AU (1) AU1392700A (de)
CA (1) CA2369115A1 (de)
DE (1) DE69926795T2 (de)
FR (1) FR2787449B3 (de)
WO (1) WO2000035879A1 (de)

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2719311B1 (fr) * 1994-03-18 1998-06-26 Sanofi Sa Composés antagonistes sélectifs du récepteur NK3 humain et leur utilisation comme médicaments et outils de diagnostic.
FR2738819B1 (fr) 1995-09-14 1997-12-05 Sanofi Sa Nouveaux composes antagonistes selectifs du recepteur nk3 humain, procede pour leur obtention et compositions pharmaceutiques les contenant
FR2745811B1 (fr) 1996-03-07 1998-05-22 Sanofi Sa Glutarimide disubstitue procede pour sa preparation, et son utilisation
JP2000515534A (ja) 1996-08-05 2000-11-21 スミスクライン・ビーチャム・ソシエタ・ペル・アチオニ ３，３―二置換ピペリジンの製造方法
GB9714129D0 (en) * 1997-07-04 1997-09-10 Pfizer Ltd Azetidines

Also Published As

Publication number Publication date
FR2787449B3 (fr) 2001-01-12
WO2000035879A1 (fr) 2000-06-22
US6342607B1 (en) 2002-01-29
JP2002532474A (ja) 2002-10-02
AU1392700A (en) 2000-07-03
DE69926795D1 (de) 2005-09-22
EP1140841B1 (de) 2005-08-17
EP1140841A1 (de) 2001-10-10
WO2000035879A8 (fr) 2001-11-22
DE69926795T2 (de) 2006-06-08
FR2787449A1 (fr) 2000-06-23
US6452012B1 (en) 2002-09-17
CA2369115A1 (en) 2000-06-22

Similar Documents

Publication Publication Date Title
DE69532137D1 (de) Verbessertes verfahren zur stabilisierung biologischer substanzen während der trocknung und anschliessender lagerung sowie die entsprechenden zusammensetzungen
DE69941954D1 (de) Oxetanderivate, oxetancopolymer, und verfahren zur herstellung von oxetanderivaten
DE59906105D1 (de) Verfahren zur kontinuierlichen herstellung von 1,3-dioxolan-2-onen
DE60222645D1 (de) Verfahren zur herstellung von oxazolidinonen
DE60133817D1 (de) Verfahren zur herstellung von aplidin und neue antitumoralen derivate, verfahren zu deren herstellung und zu deren verwendung
DE69708415T2 (de) Verfahren zur Herstellung luftgeschmierter, hydrodynamischer Keramiklager
DE60239842D1 (de) Verfahren zur Herstellung von 10,11-dihydro-10-oxo-5h-dibenzoÄb,fÜazepin-5-carboxamid
DE60210778D1 (de) Verfahren zur herstellung von 4-amino-2,5-bisheterocyclylchinazolinen
DE69928463D1 (de) Verfahren zur Herstellung von Stahlkomponenten
DE10085452T1 (de) Verfahren zur Herstellung von 1,1,1,2-Tetrafluorethan
DE60222806D1 (de) Verfahren zur herstellung von (1,4,5)-oxadiazepinderivaten
DE59900393D1 (de) Verfahren zur Herstellung von Organochlorsilanen
DE69936449D1 (de) Verfahren zur herstellung von 1,3-disubstituierten-4-oxocyclischen harnstoffen
ATE299851T1 (de) Verfahren zur herstellung von zwischenprodukten
ATE331706T1 (de) Coniosetin und derivate davon, verfahren zur herstellung und verwendung derselben
DE69913635D1 (de) Verfahren zur Herstellung von 1,3-Dialkyl-2-Imidazolinonderivaten
DE50000038D1 (de) Verfahren zur Herstellung von Organochlorsilanen
ATE302186T1 (de) Derivate von 3-phenyl-2, 6-dioxopiperidin-3-yl propionamide und verfahren zur deren herstellung
DE60004931D1 (de) Kontinuierliches Verfahren zur Herstellung von 3,5,5-Trimethylcyclohexa-3-en-1-on(beta-Isophoron)
DE60104789D1 (de) Verfahren zur Herstellung von 2,4,5-Trialkylbenzaldehyden
DE60002254T2 (de) Verfahren zur Herstellung von 4,6-diaminoresorcin
DE69920003D1 (de) Verfahren zur herstellung von 1,3-disubstituierten-4-oxocyclischen harnstoffen
DE50000040D1 (de) Verfahren zur Herstellung von Organochlorsilanen
DE60208551D1 (de) Verfahren zur herstellung von racemischen und enantiomerenreinen derivaten von 1,5-diaryl-3-trifluormethyl-delta2-pyrazolinen
DE60230097D1 (de) Verfahren zur herstellung von 1,5-diaminonaphthalinen

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties